Header Logo

Connection

Matthew Meriggioli to Activities of Daily Living

Back to Details
This is a "connection" page, showing publications Matthew Meriggioli has written about Activities of Daily Living.
Matthew Meriggioli
Connection Strength
0.165
Activities of Daily Living
  1. Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study. J Clin Neurosci. 2024 Jan; 119:76-84.
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.